M C53 (Carbidopa and Levodopa (Orally Disintegrating) 25 mg / 250 mg)
Pill with imprint M C53 is Green, Round and has been identified as Carbidopa and Levodopa (Orally Disintegrating) 25 mg / 250 mg. It is supplied by Mylan Pharmaceuticals Inc..
Carbidopa/levodopa is used in the treatment of parkinson's disease; neuroleptic malignant syndrome; gtp-ch deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 25 mg / 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for M C53
- M C53
- 25 mg / 250 mg
- 15.00 mm
- Prescription only
- Drug Class
- Dopaminergic antiparkinsonism agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC)
- Inactive Ingredients
aspartame, mannitol, microcrystalline cellulose, silicon dioxide, sodium stearyl fumarate, sorbitol, FD&C Blue No. 1, D&C Yellow No. 10
Note: Inactive ingredients may vary.
More about carbidopa / levodopa
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Pricing & Coupons
- 69 Reviews
- Drug class: dopaminergic antiparkinsonism agents
- Carbidopa and levodopa
- Carbidopa and levodopa enteral
- Carbidopa and Levodopa Extended-Release Tablets
- Carbidopa and Levodopa Orally Disintegrating Tablets
- Carbidopa and Levodopa Tablets
- ... +4 more
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.